Clinical trial
Combination Chemotherapy in Treating Children With Astrocytomas and Primitive…
NCT00002463 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00002463 |
|---|---|
| Title | Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors |
| Official title | Phase II Study of Methotrexate, Mechlorethamine, Vincristine, Prednisone, and Procarbazine (MMOPP) as Primary Therapy in Infants or Young Children With Primitive Neuroectodermal Tumors or High-Grade Astrocytoma |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure |
| Interventions | MOPP Regimen, Leucovorin Calcium, Mechlorethamine Hydrochloride, Methotrexate, Prednisone, Procarbazine Hydrochloride, Vincristine Sulfate, Conventional Surgery |
| Enrollment | 4 |
| Start date | Feb 1, 1989 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Apr 22, 2004 |
| Last update posted | Feb 18, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: